Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TherapeuticsMD (TXMD)
NASDAQ:TXMD
TherapeuticsMD (TXMD) Stock Price & Analysis
2,221 Followers
TXMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.43 - $4.35
Previous Close$1.83
Volume12.76K
Average Volume (3M)17.05K
Market Cap
$21.34M
Enterprise Value$16.78M
Total Cash (Recent Filing)$4.33M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Aug 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding11,532,443
10 Day Avg. Volume15,490
30 Day Avg. Volume17,046
Standard Deviation0.23
R-Squared0.05
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)1.03
Price to Sales (P/S)17.01
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.59
Enterprise Value/Gross Profit12.89
Enterprise Value/Ebitda-0.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TherapeuticsMD News
PremiumCompany Announcements
TherapeuticsMD Releases Preliminary Q1 2024 Financials
PremiumCompany Announcements
TherapeuticsMD Announces 2023 Annual Financial Results
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TXMD FAQ
What was TherapeuticsMD’s price range in the past 12 months?
TherapeuticsMD lowest stock price was $1.43 and its highest was $4.35 in the past 12 months.
What is TherapeuticsMD’s market cap?
Currently, no data Available
When is TherapeuticsMD’s upcoming earnings report date?
TherapeuticsMD’s upcoming earnings report date is Aug 07, 2024 which is in 16 days.
How were TherapeuticsMD’s earnings last quarter?
TherapeuticsMD released its earnings results on May 10, 2024. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.07.
Is TherapeuticsMD overvalued?
According to Wall Street analysts TherapeuticsMD’s price is currently Overvalued.
Does TherapeuticsMD pay dividends?
TherapeuticsMD does not currently pay dividends.
What is TherapeuticsMD’s EPS estimate?
TherapeuticsMD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TherapeuticsMD have?
TherapeuticsMD has 11,532,443 shares outstanding.
What happened to TherapeuticsMD’s price movement after its last earnings report?
TherapeuticsMD reported an EPS of -$0.07 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.463%.
Which hedge fund is a major shareholder of TherapeuticsMD?
Currently, no hedge funds are holding shares in TXMD
---
TherapeuticsMD Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.04%
12-Months-Change
Fundamentals
Return on Equity
-20.43%
Trailing 12-Months
Asset Growth
-29.38%
Trailing 12-Months
Company Description
TherapeuticsMD
TherapeuticsMD, Inc. is a pharmaceutical company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
---
TXMD Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Bausch Health Companies
―
Amneal Pharmaceuticals
―
Alnylam Pharma
―
Sorrento Therapeutics
―
---